BML (TSE:4694) Total Liabilities: 円51,121 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4694 BML Inc TSE:4694
79 GF Score
Price 円3,630.00
GF Value 円3,824.43
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is BML Total Liabilities?

BML TSE:4694 -0.14% 79 Total Liabilities is 円51,121 Mil as of Mar. 2026. GuruFocus rates TSE:4694 with a GF Score™ of 79/100 and a GF Value™ of 円3,824.43 (Fairly Valued). The stock has 2 warning signs investors should review.

BML's Total Liabilities for the quarter that ended in Mar. 2026 was 円51,121 Mil.

BML's quarterly Total Liabilities increased from Sep. 2025 (円43,807.00 Mil) to Dec. 2025 (円46,732.00 Mil) and increased from Dec. 2025 (円46,732.00 Mil) to Mar. 2026 (円51,121.00 Mil).

BML's annual Total Liabilities increased from Mar. 2024 (円40,854.00 Mil) to Mar. 2025 (円49,103.00 Mil) and increased from Mar. 2025 (円49,103.00 Mil) to Mar. 2026 (円51,121.00 Mil).

BML Total Liabilities Historical Data

* Premium members only.

The historical data trend for BML's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BML Total Liabilities Chart

BML Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 57,519.00 42,195.00 40,854.00 49,103.00 51,121.00

BML Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49,103.00 42,815.00 43,807.00 46,732.00 51,121.00
TSE:4694
79GF Score
BML Inc TSE:4694
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BML Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

BML's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=40887+(3170+514
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+6550+0)
=51,121

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=183247-132126
=51,121

BML's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=40887+(3170+514
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+6550+0)
=51,121

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=183247-132126
=51,121

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of 円51,121 Mil mean?
BML (TSE:4694) has a Total Liabilities of 円51,121 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for BML and its competitors.
Is BML's Total Liabilities too high?
BML's current Total Liabilities is 円51,121 Mil. Overall, BML has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does BML's Total Liabilities compare to TMO and DHR?
BML's Total Liabilities of 円51,121 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Diagnostics & Research company?
A good Total Liabilities depends on the Medical Diagnostics & Research industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for BML and its competitors. BML's current Total Liabilities is 円51,121 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BML stock overvalued right now?
Based on GuruFocus' analysis, BML (TSE:4694) is currently considered Fairly Valued. The stock's GF Value™ is 円3,824.43, compared to a current price of 円3,630.00 — trading 5.1% below its estimated fair value. The current Total Liabilities is 円51,121 Mil. BML's overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For BML (TSE:4694), the current Total Liabilities is 円51,121 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BML (TSE:4694) Overvalued in 2026?

Based on GuruFocus' analysis, BML stock appears to be undervalued. The current stock price of 円3,630.00 is trading 5.1% below its estimated GF Value™ of 円3,824.43. GuruFocus considers BML to be Fairly Valued.

Key valuation signals for TSE:4694:

  • Total Liabilities: 円51,121 Mil
  • GF Value™: 円3,824.43 vs. price of 円3,630.00 (5.1% below fair value)
  • GF Score™: 79/100 with 2 warning signs

No single metric tells the full story. See the TSE:4694 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BML Business Description

Address 5-21-3 Sendagaya, Shibuya-ku, Tokyo, JPN, 1510051
BML Inc provides laboratory testing services in Japan through a network of regional facilities. Its core clinical testing business provides a range of general and specialty laboratory tests, as well as microbiological tests that can be used for applications like food sanitation and environmental analysis. BML often uses automated systems to process and analyze these test samples. In addition to its clinical testing business, BML also has a medical information systems business and a genome-related business. The medical information systems business provides electronic medical charts and information systems that can be used in conjunction with its laboratory tests. The genome business provides gene analysis services.
79GF Score

Get the complete analysis for TSE:4694

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,630.00
Price
円3,824.43
GF Value